Adiponectin was inversely associated with type 2 diabetes even after adjustment for HOMA-IR among women (HR = 0.68; 95% CI = 0.55–0.84), but not among men (HR = 0.80; 95% CI = 0.62–104). Here, ADIPOQ is linked to type 2 diabetes mellitus.